Power Law company profile

Prevail Therapeutics

Biotech & Life Sciences · New York City, United States · Founded 2017 · IPO 2019 Unicorn

A biotechnology company

Valuation

$1.04B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

7 investors on Prevail Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

OrbiMed

Series B+ 6 investors entered at this stage

EcoR1 Capital

Abbvie Biotech Ventures

Omega Funds

RA Capital Management

Alexandria Venture Investments

Boxer Capital

Global footprint

Where Prevail Therapeutics has talent and traffic

Workforce by country

5 countries with
team presence

🇺🇸 United States94.1%

🇮🇹 Italy4.4%

🇯🇵 Japan3.1%

🇫🇷 France2.9%

🇨🇭 Switzerland2.6%

5 countries shown

Web traffic by country

680 monthly visits
across markets

🇺🇸 United States102.9%

Top 1 markets shown

Patent intelligence

$20M patent portfolio · 19 active families

Estimated portfolio value

$20M

1.9% of market cap · 102.8× smaller than top peer Ablynx ($2B)

19 active patent families

Where Prevail Therapeutics innovates Molecular biologyLysosomeTransgeneGlucocerebrosidaseCerebroside

Where Prevail Therapeutics concentrates vs peers

Each axis is a top-10 topic across Prevail Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Prevail Therapeutics

An AI-synthesized read of the highest-engagement posts about Prevail Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Prevail Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles